Ilse Van Aelst

The Hemopexin and O-Glycosylated Domains Tune Gelatinase B/MMP-9 Bioavailability via Inhibition and Binding to Cargo Receptors

Philippe E. Van den Steen, Ilse Van Aelst, Vibeke Hvidberg et al. · Journal of Biological Chemistry · 2006 · 186 citations · Full text

Immunology, Heme Trafficking, Mmp-9 Substrates +17

Functional Comparison of Two Human Monocyte Chemotactic Protein-2 Isoforms, Role of the Amino-Terminal Pyroglutamic Acid and Processing by CD26/Dipeptidyl Peptidase IV

Els Van Coillie, Paul Proost, Ilse Van Aelst et al. · Biochemistry · 1998 · 152 citations

Immunopathology and Dexamethasone Therapy in a New Model for Malaria-associated Acute Respiratory Distress Syndrome

Philippe E. Van den Steen, Nathalie Geurts, Katrien Deroost et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 127 citations

CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN‐γ‐induced chemokines

Philippe E. Van den Steen, Katrien Deroost, Ilse Van Aelst et al. · European Journal of Immunology · 2008 · 98 citations · Full text

Chemokine Biology, Immunology, Immune Regulation +17

A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains

Erik Martens, An Leyssen, Ilse Van Aelst et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2006 · 95 citations

Catalytic Domain, Gelatinase B/mmp-9, Immunology +9